Unknown Manufacturer • Fezolinetant is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.
Fezolinetant is a non-hormonal drug used to treat moderate to severe vasomotor symptoms due to menopause
Fezolinetant is a neurokinin 3 (NK3) receptor antagonist that blocks neurokinin B (NKB) binding on the kisspeptin/neurokinin B/dynorphin (KNDy) neuron to modulate neuronal activity in the thermoregulatory center.
